Human ICOS/CD278 Protein (ICO-HM101)

  • Express System: Expi293
  • Product Tag: C-His
  • Purity: > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC
  • Activity: Immobilized Human ICOS, His Tag at 0.5μg/ml (100μl/Well) on the plate. Dose response curve for Human B7-H2, hFc Tag with the EC50 of 22.7ng/ml determined by ELISA. See testing image for detail.
  • Exact Sequence: Glu21-Gln134

Catalog: ICO-HM101

$394.00
Size:

Order now get it on

Product Description Recombinant Human ICOS/CD278 Protein is expressed from Expi293 with His tag at the C-terminal.It contains Glu21-Gln134.
Product Category Recombinant Protein
Target ICOS/CD278
Synonyms AILIM; CD278; CRP-1; CVID1; ICOS; MGC39850
Gene/Protein ID Q9Y6W8-1
Species Human
Exact Sequence Glu21-Gln134
Molecular Weight The protein has a predicted MW of 14.6 kDa. Due to glycosylation, the protein migrates to 25-35 kDa based on Tris-Bis PAGE result.
Activity Immobilized Human ICOS, His Tag at 0.5μg/ml (100μl/Well) on the plate. Dose response curve for Human B7-H2, hFc Tag with the EC50 of 22.7ng/ml determined by ELISA. See testing image for detail.
Product Tag C-His
Express System Expi293
Purity > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC
Endotoxin Less than 1EU per μg by the LAL method.
Form Liquid
Shipping Shipped with blue ice.
Formulation Supplied as 0.22μm filtered solution in PBS (pH 7.4). Please dilute to the desired concentration according to the concentration of the solution shown on the product label.
Stability And Storage Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please do not repeated freeze-thaw cycles.
Immobilized Human ICOS, His Tag at 0.5μg/ml (100μl/Well) on the plate. Dose response curve for Human B7-H2, hFc Tag with the EC50 of 22.7ng/ml determined by ELISA.
The purity of Human ICOS is greater than 95% as determined by SEC-HPLC.
Human ICOS on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.

You may also be interested in